NOROXIN Side Effects

6955958-3 | Abortion Induced
on Aug 25, 2010 Female patient from SWITZERLAND , 19 years of age, was diagnosed with cystitis, vaginal infection and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: abortion induced. Noroxin dosage: . During the same period patient was treated with FLAGYL (View Flagyl Review and Flagyl Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ).

6934102-2 | Agranulocytosis, Oral Candidiasis
Patient was taking Noroxin (View Usage). Patient had the following side effects: agranulocytosis, oral candidiasis on Aug 12, 2010 from AUSTRALIA Additional patient health information: Female patient , 63 years of age, weighting 116.8 lb, . Noroxin dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6929147-2 | Cheilitis, Oropharyngeal Pain
Adverse event was reported on Aug 16, 2010 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?), dyslipidaemia, hypertension and. Location: FRANCE , 79 years of age, After Noroxin was administered, patient had the following side effects: cheilitis, oropharyngeal pain. During the same period patient was treated with ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (View Bisoprolol Fumarate And Hydrochlorothiazide Review and Bisoprolol Fumarate And Hydrochlorothiazide Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DESLORATADINE (View Desloratadine Review and Desloratadine Label ). Patient was hospitalized.

6925585-2 | Anaemia, Haematoma, International Normalised Ratio Increased
on Aug 12, 2010 Female patient from FRANCE , 96 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), atrial fibrillation (What is atrial fibrillation?) and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, haematoma, international normalised ratio increased. Noroxin dosage: . During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.


6923389-8 | Agranulocytosis, Oral Candidiasis
on Aug 12, 2010 Female patient from AUSTRALIA , 63 years of age, weighting 116.8 lb, was treated with Noroxin (View Usage). Patient had the following side effects: agranulocytosis, oral candidiasis. Noroxin dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6860827-3 | Cytolytic Hepatitis
Patient was taking Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: cytolytic hepatitis on Jul 16, 2010 from FRANCE Additional patient health information: Female patient , 45 years of age, was diagnosed with dysuria and. Noroxin dosage: . During the same period patient was treated with PREDNISOLONE SODIUM METAZOATE (View Prednisolone Sodium Metazoate Review and Prednisolone Sodium Metazoate Label ). Patient was hospitalized.

6766528-4 | Interstitial Lung Disease
Adverse event was reported on Jun 03, 2010 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with prophylaxis, urinary tract infection (What is urinary tract infection?) and. Location: JAPAN , 72 years of age, Patient experienced the following unwanted or unexpected effects: interstitial lung disease. During the same period patient was treated with CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), CRAVIT (View Cravit Review and Cravit Label ).

6757097-3 | Interstitial Lung Disease
on May 27, 2010 Female patient from JAPAN , 72 years of age, was diagnosed with prophylaxis and was treated with Noroxin (View Usage). Patient had the following side effects: interstitial lung disease. Noroxin dosage: . During the same period patient was treated with CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ).

6744314-9 | Interstitial Lung Disease
on May 18, 2010 Female patient from JAPAN , 72 years of age, was diagnosed with cystitis and was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: interstitial lung disease. Noroxin dosage: . During the same period patient was treated with CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

6722727-9 | Arthralgia, Erythema Nodosum, Myalgia, Toxic Skin Eruption
Patient was taking Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, erythema nodosum, myalgia, toxic skin eruption on May 07, 2010 from FRANCE Additional patient health information: Male patient , 53 years of age, was diagnosed with prostatitis, pain (What is pain?) and. Noroxin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6718614-2 | Asthenia, Hypochloraemia, Hypokalaemia, Hyponatraemia, Vomiting
Adverse event was reported on May 06, 2010 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with cystitis, hypertension, atrial fibrillation (What is atrial fibrillation?) and. Location: FRANCE , 83 years of age, Patient had the following side effects: asthenia, hypochloraemia, hypokalaemia, hyponatraemia, vomiting. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), COTAREG (View Cotareg Review and Cotareg Label ), CORDARONE (View Cordarone Review and Cordarone Label ), PREVISCAN (View Previscan Review and Previscan Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), IMOVANE (View Imovane Review and Imovane Label ), COZAAR (View Cozaar Review and Cozaar Label ). Patient was hospitalized.

6698876-0 | Face Oedema, Oedema Peripheral, Pruritus, Rash Erythematous, Toxic Skin Eruption
on Apr 23, 2010 Female patient from FRANCE , 57 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: face oedema, oedema peripheral, pruritus, rash erythematous, toxic skin eruption. Noroxin dosage: . Patient was hospitalized.

6697680-7 | Depression, Dyspnoea, Headache, Myalgia, Retching, Tendonitis, Vision Blurred
on Apr 14, 2010 Male patient from AUSTRALIA , 50 years of age, weighting 178.6 lb, was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), dyspnoea, headache (What is headache?), myalgia, retching, tendonitis, vision blurred. Noroxin dosage: .

6696854-9 | Face Oedema, Oedema Peripheral, Pruritus, Rash Erythematous, Toxic Skin Eruption
Patient was taking Noroxin (View Usage). Patient had the following side effects: face oedema, oedema peripheral, pruritus, rash erythematous, toxic skin eruption on Apr 21, 2010 from FRANCE Additional patient health information: Female patient , 57 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Noroxin dosage: . Patient was hospitalized.

6688563-7 | Depression, Dyspnoea, Headache, Myalgia, Retching, Tendonitis, Vision Blurred
Adverse event was reported on Apr 14, 2010 by a Male patient taking Noroxin (View Usage) (Dosage: ) . Location: AUSTRALIA , 50 years of age, weighting 178.6 lb, After Noroxin was administered, patient had the following side effects: depression (What is depression?), dyspnoea, headache (What is headache?), myalgia, retching, tendonitis, vision blurred.

6678137-6 | Erythema Nodosum, Toxic Skin Eruption
on Apr 09, 2010 Male patient from FRANCE , 53 years of age, was diagnosed with prostatitis and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: erythema nodosum, toxic skin eruption. Noroxin dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

6667585-6 | Blood Creatinine Increased, Confusional State, Hepatic Encephalopathy, International Normalised Ratio Increased, Overdose, Rectal Haemorrhage
on Mar 30, 2010 Male patient from FRANCE , 77 years of age, was diagnosed with peritoneal infection, portal vein thrombosis and was treated with Noroxin (View Usage). Patient had the following side effects: blood creatinine increased, confusional state, hepatic encephalopathy, international normalised ratio increased, overdose, rectal haemorrhage. Noroxin dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

6647512-8 | Muscular Weakness, Paralysis
Patient was taking Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: muscular weakness, paralysis (What is paralysis?) on Mar 16, 2010 from AUSTRALIA Additional patient health information: Male patient , 55 years of age, was diagnosed with food poisoning and. Noroxin dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ZOCOR (View Zocor Review and Zocor Label ), DIAMICRON (View Diamicron Review and Diamicron Label ).

6640570-6 | Muscular Weakness, Paralysis
Adverse event was reported on Mar 01, 2010 by a Male patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with food poisoning and. Location: AUSTRALIA , 55 years of age, Patient experienced the following unwanted or unexpected effects: muscular weakness, paralysis (What is paralysis?). During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ZOCOR (View Zocor Review and Zocor Label ), DIAMICRON (View Diamicron Review and Diamicron Label ).

6633618-6 | Muscular Weakness, Paralysis
on Mar 10, 2010 Male patient from AUSTRALIA , 55 years of age, was diagnosed with food poisoning and was treated with Noroxin (View Usage). Patient had the following side effects: muscular weakness, paralysis (What is paralysis?). Noroxin dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ZOCOR (View Zocor Review and Zocor Label ), DIAMICRON (View Diamicron Review and Diamicron Label ).

6616093-7 | Muscular Weakness, Paralysis
on Mar 01, 2010 Male patient from AUSTRALIA , 55 years of age, was diagnosed with food poisoning and was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: muscular weakness, paralysis (What is paralysis?). Noroxin dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ZOCOR (View Zocor Review and Zocor Label ), DIAMICRON (View Diamicron Review and Diamicron Label ).

6585515-2 | Overdose
Patient was taking Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: overdose on Feb 11, 2010 from FRANCE Additional patient health information: Male patient , 77 years of age, was diagnosed with peritoneal infection, portal vein thrombosis and. Noroxin dosage: . During the same period patient was treated with FLUINDIONE (View Fluindione Review and Fluindione Label ). Patient was hospitalized.

6583103-5 | International Normalised Ratio Increased
Adverse event was reported on Feb 11, 2010 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with cystitis, deep vein thrombosis (What is deep vein thrombosis?) and. Location: FRANCE , 43 years of age, Patient had the following side effects: international normalised ratio increased. During the same period patient was treated with FLUINDIONE (View Fluindione Review and Fluindione Label ), FOSFOMYCIN TROMETHAMINE (View Fosfomycin Tromethamine Review and Fosfomycin Tromethamine Label ), GEMCITABINE (View Gemcitabine Review and Gemcitabine Label ). Patient was hospitalized.

6574368-4 | Erythema Nodosum
on Feb 03, 2010 Male patient from FRANCE , 53 years of age, was diagnosed with prostatitis and was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: erythema nodosum. Noroxin dosage: . During the same period patient was treated with BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

6491665-1 | Haemorrhagic Anaemia, International Normalised Ratio Increased, Peritoneal Haemorrhage, Shock Haemorrhagic
on Dec 04, 2009 Female patient from FRANCE , 57 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), aortic valve replacement, hyperthyroidism and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhagic anaemia, international normalised ratio increased, peritoneal haemorrhage, shock haemorrhagic. Noroxin dosage: . During the same period patient was treated with PROPRANOLOL HYDROCHLORIDE (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), CARBIMAZOLE (View Carbimazole Review and Carbimazole Label ). Patient was hospitalized.

6468135-X | Melaena, Rectal Haemorrhage
Patient was taking Noroxin (View Usage). Patient had the following side effects: melaena, rectal haemorrhage on Nov 27, 2009 from FRANCE Additional patient health information: Female patient , 96 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Noroxin dosage: . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), TRIMETAZIDINE HYDROCHLORIDE (View Trimetazidine Hydrochloride Review and Trimetazidine Hydrochloride Label ), NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ). Patient was hospitalized.

6461837-0 | Amniotic Band Syndrome
Adverse event was reported on Nov 17, 2009 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with abdominal pain (What is abdominal pain?) and. Location: INDIA , 24 years of age, After Noroxin was administered, patient had the following side effects: amniotic band syndrome. During the same period patient was treated with DICYCLOMINE HYDROCHLORIDE (View Dicyclomine Hydrochloride Review and Dicyclomine Hydrochloride Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), AMINOCAPROIC ACID (View Aminocaproic Acid Review and Aminocaproic Acid Label ).

6458249-2 | Parkinson's Disease, Rash Maculo-papular
on Nov 19, 2009 Female patient from SWITZERLAND , 77 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: parkinson's disease (What is parkinson's disease?), rash maculo-papular. Noroxin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), BENSERAZIDE HYDROCHLORIDE AND LEVODOPA (View Benserazide Hydrochloride And Levodopa Review and Benserazide Hydrochloride And Levodopa Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ).

6427019-3 | Malaise, Petit Mal Epilepsy
on Oct 29, 2009 Female patient from FRANCE , 87 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), hypertension and was treated with Noroxin (View Usage). Patient had the following side effects: malaise, petit mal epilepsy. Noroxin dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), PAROXETINE HYDROCHLORIDE (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ). Patient was hospitalized.

6427007-7 | Paralysis
Patient was taking Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: paralysis (What is paralysis?) on Oct 23, 2009 from AUSTRALIA Additional patient health information: Male patient , 55 years of age, was diagnosed with food poisoning and. Noroxin dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ZOCOR (View Zocor Review and Zocor Label ), DIAMICRON (View Diamicron Review and Diamicron Label ).

6397248-6 | Ageusia
Adverse event was reported on Oct 08, 2009 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 38 years of age, Patient experienced the following unwanted or unexpected effects: ageusia.

6383121-6 | Angioedema, Eyelid Oedema, Urticaria
on Sep 22, 2009 Female patient from FRANCE , 18 years of age, was diagnosed with abdominal pain (What is abdominal pain?), urinary tract infection (What is urinary tract infection?) and was treated with Noroxin (View Usage). Patient had the following side effects: angioedema, eyelid oedema, urticaria. Noroxin dosage: . During the same period patient was treated with CEFIXIME (View Cefixime Review and Cefixime Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

6383116-2 | Pseudomembranous Colitis
on Sep 22, 2009 Male patient from FRANCE , 76 years of age, was diagnosed with dysuria, bladder spasm, lung disorder, crohn's disease (What is crohn's disease?) and was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: pseudomembranous colitis. Noroxin dosage: . During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ). Patient was hospitalized.

6381040-2 | Angioedema, Eyelid Oedema, Urticaria
Patient was taking Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, eyelid oedema, urticaria on Sep 22, 2009 from FRANCE Additional patient health information: Female patient , 18 years of age, was diagnosed with abdominal pain (What is abdominal pain?), urinary tract infection (What is urinary tract infection?) and. Noroxin dosage: . During the same period patient was treated with CEFIXIME (View Cefixime Review and Cefixime Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

6380055-8 | Pseudomembranous Colitis
Adverse event was reported on Sep 22, 2009 by a Male patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?), lung disorder, crohn's disease (What is crohn's disease?) and. Location: FRANCE , 76 years of age, Patient had the following side effects: pseudomembranous colitis. During the same period patient was treated with LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), CEFTRIAXONE SODIUM (View Ceftriaxone Sodium Review and Ceftriaxone Sodium Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ). Patient was hospitalized.

6336684-0 | Pruritus, Rash Maculo-papular, Vulvitis
on Aug 27, 2009 Female patient from FRANCE , 75 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: pruritus, rash maculo-papular, vulvitis. Noroxin dosage: . During the same period patient was treated with PEMETREXED DISODIUM (View Pemetrexed Disodium Review and Pemetrexed Disodium Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6286891-0 | Arthralgia, Memory Impairment, Myalgia, Paraesthesia, Visual Acuity Reduced
on Jul 23, 2009 Female patient from FRANCE , 50 years of age, was diagnosed with cystitis and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, memory impairment, myalgia, paraesthesia, visual acuity reduced. Noroxin dosage: .

6267500-3 | Ageusia
Patient was taking Noroxin (View Usage). Patient had the following side effects: ageusia on Jul 07, 2009 from FRANCE Additional patient health information: Female patient , 38 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Noroxin dosage: .

6258778-0 | Vascular Purpura
Adverse event was reported on Jun 29, 2009 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , 30 years of age, After Noroxin was administered, patient had the following side effects: vascular purpura. Patient was hospitalized.

6257402-0 | Henoch-schonlein Purpura, Leukocytoclastic Vasculitis
on Jun 16, 2009 Male patient from SPAIN , 65 years of age, was diagnosed with orchitis, atrial fibrillation (What is atrial fibrillation?) and was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: henoch-schonlein purpura, leukocytoclastic vasculitis. Noroxin dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ). Patient was hospitalized.

6253184-7 | Pyrexia, Toxic Skin Eruption
on Jun 25, 2009 Male patient from FRANCE , 68 years of age, was treated with Noroxin (View Usage). Patient had the following side effects: pyrexia, toxic skin eruption. Noroxin dosage: . During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ). Patient was hospitalized.

6243338-8 | Henoch-schonlein Purpura, Leukocytoclastic Vasculitis
Patient was taking Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: henoch-schonlein purpura, leukocytoclastic vasculitis on Jun 16, 2009 from SPAIN Additional patient health information: Male patient , 65 years of age, was diagnosed with orchitis, atrial fibrillation (What is atrial fibrillation?) and. Noroxin dosage: . During the same period patient was treated with ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ). Patient was hospitalized.

6237617-8 | Cytolytic Hepatitis
Adverse event was reported on May 28, 2009 by a Male patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with pyrexia, diarrhoea, hip arthroplasty, cardiovascular event prophylaxis, diabetes mellitus and. Location: FRANCE , 70 years of age, Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. During the same period patient was treated with DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), METFORMIN PAMOATE (View Metformin Pamoate Review and Metformin Pamoate Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), PINAVERIUM BROMIDE (View Pinaverium Bromide Review and Pinaverium Bromide Label ). Patient was hospitalized.

6229716-1 | Nasopharyngitis, Vestibular Neuronitis
on Jun 05, 2009 Female patient from FRANCE , 78 years of age, was diagnosed with cystitis, hypertension and was treated with Noroxin (View Usage). Patient had the following side effects: nasopharyngitis, vestibular neuronitis. Noroxin dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCHLOROTHIAZIDE AND LISINOPRIL (View Hydrochlorothiazide And Lisinopril Review and Hydrochlorothiazide And Lisinopril Label ). Patient was hospitalized.

6216502-1 | Fall
on May 27, 2009 Female patient from FRANCE , 88 years of age, was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: fall (What is fall?). Noroxin dosage: . During the same period patient was treated with ACETAMINOPHEN AND PROPOXYPHENE HYDROCHLORIDE (View Acetaminophen And Propoxyphene Hydrochloride Review and Acetaminophen And Propoxyphene Hydrochloride Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), ESTAZOLAM (View Estazolam Review and Estazolam Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ). Patient was hospitalized.

6216487-8 | Cytolytic Hepatitis
Patient was taking Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis on May 28, 2009 from FRANCE Additional patient health information: Male patient , 70 years of age, was diagnosed with pyrexia, diarrhoea, hip arthroplasty, cardiovascular event prophylaxis, diabetes mellitus and. Noroxin dosage: . During the same period patient was treated with DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), METFORMIN PAMOATE (View Metformin Pamoate Review and Metformin Pamoate Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), PINAVERIUM BROMIDE (View Pinaverium Bromide Review and Pinaverium Bromide Label ). Patient was hospitalized.

6200029-7 | Gingival Bleeding, Purpura, Thrombocytopenia
Adverse event was reported on May 13, 2009 by a Female patient taking Noroxin (View Usage) (Dosage: ) was diagnosed with cystitis, hypertension, type 2 diabetes mellitus, gout (What is gout?) and. Location: FRANCE , 88 years of age, Patient had the following side effects: gingival bleeding, purpura, thrombocytopenia. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), URAPIDIL (View Urapidil Review and Urapidil Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6167145-X | Anaphylactic Shock, Angioedema, Headache, Loss Of Consciousness
on Apr 21, 2009 Female patient from ITALY , 44 years of age, was treated with Noroxin (View Usage). After Noroxin was administered, patient had the following side effects: anaphylactic shock, angioedema, headache (What is headache?), loss of consciousness. Noroxin dosage: .

6165875-7 | Blood Alkaline Phosphatase Increased, Cholestasis, Condition Aggravated, Cytolytic Hepatitis, Gamma-glutamyltransferase Increased, Transaminases Increased
on Apr 14, 2009 Male patient from FRANCE , 85 years of age, was treated with Noroxin (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, cholestasis, condition aggravated, cytolytic hepatitis, gamma-glutamyltransferase increased, transaminases increased. Noroxin dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6119741-3 | International Normalised Ratio Increased
Patient was taking Noroxin (View Usage). Patient had the following side effects: international normalised ratio increased on Mar 09, 2009 from SWITZERLAND Additional patient health information: Female patient , 88 years of age, weighting 127.9 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?), abdominal pain upper and. Noroxin dosage: . During the same period patient was treated with SINTROM (View Sintrom Review and Sintrom Label ), NEXIUM (View Nexium Review and Nexium Label ), CO AMOXI (View Co-amoxi Review and Co-amoxi Label ), BRUFEN (View Brufen Review and Brufen Label ), CONCOR (View Concor Review and Concor Label ), EUTHYROX (View Euthyrox Review and Euthyrox Label ), TRITTICO (View Trittico Review and Trittico Label ).